Ikutani et al. demonstrated that mice with defective IL-5 signalling or treated with antibodies against IL-5 are characterized by enhanced lung melanoma metastasis and impaired eosinophil regulation [9], suggesting that the impact of IL-5 in cancer needs to be further examined. The gene discussed is IL5; the disease is cancer.